Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
64 studies found for:    antineoplastons
Show Display Options
Download search resultsDownload the search results for:
antineoplastons (64 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated
Has Results
Antineoplaston Therapy in Treating Patients With Meningioma
Condition: Meningioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
2 Completed
Has Results
Antineoplaston Therapy in Treating Children With Brain Tumors
Condition: Childhood Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
3 Terminated
Has Results
Antineoplaston Therapy in Treating Patients With Ependymoma
Condition: Ependymoma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
4 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Refractory Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
5 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
Condition: Brain Stem Gliomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
6 Completed
Has Results
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
Condition: Adult Brain Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
7 Terminated
Has Results
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: Childhood Brain Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
8 Completed
Has Results
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Condition: Low Grade Astrocytomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
9 Terminated Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Condition: CNS Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
10 Terminated
Has Results
Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Condition: Rhabdoid Neoplasm of CNS
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
11 Completed
Has Results
Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Condition: Visual Pathway Glioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
12 Completed
Has Results
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
Condition: Childhood CNS Primitive Neuroectodermal Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
13 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
Condition: Anaplastic Astrocytoma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
14 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: Malignant Brain Tumors
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
15 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Condition: Mixed Gliomas
Interventions: Drug: Atengenal;   Drug: Astugenal
16 Not yet recruiting Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
17 Not yet recruiting Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
18 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
19 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
20 Unknown  Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.